Clinical trial

Assessment of Precision Irradiation in Early NSCLC and Interstitial Lung Disease

NCT03485378

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

RADIATION · Unmapped registry intervention Stereotactic Ablative Radiotherapy Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Assessment of Precision Irradiation in Early NSCLC and Interstitial Lung Disease

Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2018-09-20

PhaseNA

Conditions

Non Small Cell Lung Cancercandidate · MONDO: non-small cell lung carcinoma

Interstitial Lung Diseaseverified · MONDO: interstitial lung disease

Interventions

Stereotactic Ablative RadiotherapyRADIATION

Sponsors & collaborators

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'slead sponsor

London Health Sciences Centrecollaborator

University of British Columbiacollaborator

Western University, Canadacollaborator

Mapped research locations

TorontoOntario, Canada2 MontrealQuebec, Canada1 EdmontonAlberta, Canada1 LondonOntario, Canada1 EdinburghUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03485378 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.